Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features.
Arduino PG, Porter SR.
J Oral Pathol Med. 2008 Feb;37(2):107-21. doi: 10.1111/j.1600-0714.2007.00586.x.
Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management.
Fatahzadeh M, Schwartz RA.
J Am Acad Dermatol. 2007 Nov;57(5):737-63; quiz 764-6. doi: 10.1016/j.jaad.2007.06.027.
The many challenges of facial herpes simplex virus infection.
Esmann J.
J Antimicrob Chemother. 2001 Feb;47 Suppl T1:17-27. doi: 10.1093/jac/47.suppl_1.17.
Facial paralysis induced by ear inoculation of herpes simplex virus in rat.
Fujiwara T, Matsuda S, Tanaka J, Hato N.
Auris Nasus Larynx. 2017 Feb;44(1):58-64. doi: 10.1016/j.anl.2016.04.002. Epub 2016 Apr 17.
The natural history of recurrent oral-facial herpes simplex virus infection.
Spruance SL.
Semin Dermatol. 1992 Sep;11(3):200-6.
Improving the outcome of facial resurfacing--prevention of herpes simplex virus type 1 reactivation.
Gilbert S.
J Antimicrob Chemother. 2001 Feb;47 Suppl T1:29-34. doi: 10.1093/jac/47.suppl_1.29.
Risk factors of facial herpes simplex after percutaneous microballoon compression for trigeminal neuralgia: A retrospective case-cohort study.
Zhang A, Li Q, Wang H, Huang H, Zhang H.
Neuro Endocrinol Lett. 2023 Mar 8;44(1):31-38.
Herpes simplex polyganglionitis.
Adour KK, Hilsinger RL Jr, Byl FM.
Otolaryngol Head Neck Surg (1979). 1980 May-Jun;88(3):270-4. doi: 10.1177/019459988008800315.
[Herpes simplex prophylaxis in facial exfoliation treatments].
Guerra A, Cisneros JL, Eiros JM, Herrera E, Jaén P, Pérez-Macías JM.
Actas Dermosifiliogr. 2005 Oct;96(8):479-97. doi: 10.1016/s0001-7310(05)73120-3.
Is prophylactic acyclovir treatment warranted for prevention of herpes simplex virus infections in facial burns? A review of the literature.
Haik J, Weissman O, Stavrou D, Ben-noon HI, Liran A, Tessone A, Zmora N, Zilinsky I, Winkler E, Gur E, Stahl S.
J Burn Care Res. 2011 May-Jun;32(3):358-62. doi: 10.1097/BCR.0b013e318217f6de.
